Air Pollution Exposure Increases Risk for Parkinson Disease
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 20, 2024 -- Higher exposure to air pollution increases the risk for Parkinson disease (PD), according to a study published online Sept. 16 in JAMA Network Open.
Brittany Krzyzanowski, Ph.D., from the Barrow Neurological Institute in Phoenix, and colleagues assessed whether air pollution is associated with an increased risk for PD and clinical characteristics of PD. The analysis included data from 346 patients with PD and 4,813 matched controls participating in the Rochester Epidemiology Project (1998 to 2015).
The researchers found that greater exposure to particulate matter with a diameter of <2.5 μm (PM2.5) was associated with increased PD risk, and this risk was greatest for populations within metropolitan cores (odds ratio [OR], 1.23) for the top quintile of PM2.5 exposure versus the bottom quintile. An increased risk for PD was also seen with greater nitrogen dioxide (NO2) exposure, when comparing the top quintile to the bottom quintile (OR, 1.13). Exposure to air pollution was associated with an increased risk for akinetic rigid presentation (OR per each 1-μg/m3 increase in PM2.5, 1.36). Among individuals with PD only, higher PM2.5 exposure was associated with a greater risk for developing dyskinesia (hazard ratio [HR] per 1-μg/m3 increase in PM2.5, 1.42), as was increased NO2 exposure (HR per 1-μg/m3 increase in NO2, 1.13).
"Importantly, in 2024, the U.S. Environmental Protection Agency reduced the annual PM2.5 standard from 12 μg/m3 to 9 μg/m3 due to growing evidence of negative health effects at levels below the previously set standard," the authors write. "Our study not only supports the findings that led to this change, but suggests that the upper limit should be lowered to 8 μg/m3."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Read this next
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DM
WEDNESDAY, Sept. 18, 2024 -- For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for incident dementia and...
Upper GI Mucosal Damage Tied to Later Parkinson Disease Diagnosis
WEDNESDAY, Sept. 11, 2024 -- A history of upper gastrointestinal mucosal damage (MD) is associated with a higher subsequent risk for developing Parkinson disease (PD), according...
Migraine in Women Not Linked to Risk for Parkinson Disease
THURSDAY, Aug. 22, 2024 -- Migraine is not associated with an increased risk for developing Parkinson disease (PD) among women, according to a study published online Aug. 21 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.